JGC
FLNA

J. Goldman & Co’s Filana Therapeutics FLNA Stock Holding History

J. Goldman & Co’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-68,993
Closed -$1.08M – 407
2016
Q1 		$1.08M Sell
68,993
-61,007
-47% -$789K 0.07% 218
2015
Q4 		$1.59M Sell
130,000
-97,724
-43% -$1.29M 0.16% 152
2015
Q3 		$2.92M Sell
227,724
-4,419
-2% -$55.8K 0.25% 121
2015
Q2 		$2.81M Buy
+232,143
New +$3.18M 0.17% 138

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

J. Goldman & Co's FLNA Position: Q2 2016 in Review

J. Goldman & Co sold out of Filana Therapeutics (FLNA) in Q2 2016, closing a stake of 68,993 shares — an estimated $1.08M sold.

J. Goldman & Co first reported a position in FLNA in Q2 2015 and held it in 4 quarters. The position peaked at $2.92M in Q3 2015. 47 funds tracked by Wall St. Rank hold FLNA as of Q2 2016.

  • J. Goldman & Co reported no remaining Filana Therapeutics position as of Q2 2016 after selling out during the quarter.
  • J. Goldman & Co sold 68,993 Filana Therapeutics shares in Q2 2016, an estimated $1.08M.
  • J. Goldman & Co first reported a position in Filana Therapeutics in Q2 2015 and held it in 4 quarters.
  • J. Goldman & Co's Filana Therapeutics position peaked at $2.92M in Q3 2015.
  • 47 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2016.

Based on J. Goldman & Co's 13F filing for Q2 2016, filed 15 Aug 2016.